391 related articles for article (PubMed ID: 5493086)
1. Antitumor properties of 1,3-oxazine derivatives. I. Derivatives of 5-nitrotetrahydro-1,3-oxazines.
Mordarski M; Chylińska B; Urbański T
Arch Immunol Ther Exp (Warsz); 1970; 18(6):679-99. PubMed ID: 5493086
[No Abstract] [Full Text] [Related]
2. Antitumor properties of 1,3-oxazine derivatives. Derivatives of dihydro-1,3-oxazine condensed with an aromatic ring in position 5,6.
Mordarski M; Chylińska JB
Arch Immunol Ther Exp (Warsz); 1971; 19(4):533-45. PubMed ID: 5095072
[No Abstract] [Full Text] [Related]
3. Antitumor properties of 1,3-oxazine derivatives. 3. The relation between chemical structure and activity in the group of nitrotetrahydro-1,3-oxazine derivatives.
Mordarski M; Chylińska B
Arch Immunol Ther Exp (Warsz); 1972; 20(4):607-17. PubMed ID: 4672978
[No Abstract] [Full Text] [Related]
4. [Antitumor properties of preparation No. 4 obtained from plants of the family Labiatae].
Krymovskaia SS; Zatula DG; Reznik SR; Zinchenko TV
Mikrobiol Zh; 1972; 33(2):217-21. PubMed ID: 4679199
[No Abstract] [Full Text] [Related]
5. [Antineoplastic activity of preparations of the series of phenoxazine dyes].
D'iachkovskaia RF; Parkhomenko II; Vasil'eva LS; Surkova NI; Shuppe NG; Konovalova NP; Bogdanov GN; Emanuel' NM
Farmakol Toksikol; 1969; 32(1):84-7. PubMed ID: 5770324
[No Abstract] [Full Text] [Related]
6. [Antitumor activity of prospidin].
Sorkina IuA; Chernov VA; Grushina AA; Khramchenkova SP
Vopr Onkol; 1970; 16(7):83-6. PubMed ID: 5274101
[No Abstract] [Full Text] [Related]
7. Effects of 4,4'-diacetyl-diphenyl-urea-bis(guanylhydrazone) on a spectrum of mouse and rat tumors.
Mihich E; Gelzer J
Cancer Res; 1968 Mar; 28(3):553-8. PubMed ID: 4966648
[No Abstract] [Full Text] [Related]
8. Further studies on the tumor inhibitory effects of carbobenzoxy derivatives of amino acids.
Shohat B; Schlesinger M; Grossowicz N; Lichtenstein N
Isr J Med Sci; 1972 Jan; 8(1):29-33. PubMed ID: 5067528
[No Abstract] [Full Text] [Related]
9. [The antitumor properties of 3,5-diglycoside-cyanidine].
Kabiev OK; Vermenichev SM
Vopr Onkol; 1970; 16(8):60-2. PubMed ID: 5537238
[No Abstract] [Full Text] [Related]
10. Antitumor effects of methylglyoxal-bis(N-4-methylthiosemicarbazone) and their potentiation in pyridoxine-deficient animals.
Mihich E; Nichol CA
Cancer Res; 1965 Jul; 25(6):794-801. PubMed ID: 5214034
[No Abstract] [Full Text] [Related]
11. Pharmacology of 1,6-Dibromo-1,6-dideoxy-dulcitol and its Cytostatic effect on transplantable tumours.
Kellner B; Németh L; Sugár J; Gáti E; Pályi I; Döbrössy L
Arzneimittelforschung; 1967 Aug; 17(8):1037-43. PubMed ID: 5244384
[No Abstract] [Full Text] [Related]
12. Antineoplastic activity of new linear hydrazine derivatives.
Fiszer-Maliszewska L; Peczyńska-Czoch W; Wieczorek J; Mordarski M; Balicki R; Nantka-Namirski P
Arch Immunol Ther Exp (Warsz); 1987; 35(2):225-35. PubMed ID: 3447537
[TBL] [Abstract][Full Text] [Related]
13. Carcinostatic effect of aliphatic aldehydes and aldehyde dehydrogenase activity in Ehrlich carcinoma, Sarcoma 180, and Yoshida AH 130 hepatoma.
Perin A; Sessa A; Ciaranfi E
Cancer Res; 1978 Jul; 38(7):2180-4. PubMed ID: 207425
[TBL] [Abstract][Full Text] [Related]
14. Experimental research in the influence of the endocrine status on the antiblastic activity of cytostatics.
Zimel H
Neoplasma; 1967; 14(4):345-52. PubMed ID: 6063010
[No Abstract] [Full Text] [Related]
15. Isothiazolopyrimidines--new group of anticancer agents. I.
Machoń Z; Wieczorek J; Mordarski M
Arch Immunol Ther Exp (Warsz); 1987; 35(5):599-607. PubMed ID: 3455649
[TBL] [Abstract][Full Text] [Related]
16. Experimental and clinical studies of the antitumor activity of 1-methyl-1-nitrosourea (NSC-23909).
Emanuel NM; Vermel EM; Ostrovskaya LA; Korman NP
Cancer Chemother Rep; 1974; 58(2):135-48. PubMed ID: 4830495
[No Abstract] [Full Text] [Related]
17. An approach to tumour biology in the light of prevention, cure and etiology.
Bose S; Chowdhury JR
Indian J Cancer; 1972 Jun; 9(2):138-41. PubMed ID: 4635904
[No Abstract] [Full Text] [Related]
18. The evaluation of antitumor properties of acridine derivatives on the basis of the results from some in vivo and in vitro tests.
Radzikowski C; Ledóchowski Z; Ledóchowski A; Wrzolek S; Hrabowska M; Konopa J
Arch Immunol Ther Exp (Warsz); 1967; 15(1):126-8. PubMed ID: 6048222
[No Abstract] [Full Text] [Related]
19. A search for new antitumor compounds. Biological studies. IV. Antitumor properties of 21 new acridine derivatives.
Radzikowski C; Ledóchowski Z; Ledóchowski A; Bogucka M; Hrabowska M; Konopa J; Balk M; Jereczek E
Arch Immunol Ther Exp (Warsz); 1967; 15(2):241-8. PubMed ID: 6050442
[No Abstract] [Full Text] [Related]
20. Antitumor properties of selected 1,2,4-triazine derivatives.
Mordarski M; Wieczorek J; Fiszer L; Nantka-Namirski P; Rykowski A
Arch Immunol Ther Exp (Warsz); 1980; 28(5):717-25. PubMed ID: 7212979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
